PMID- 25784985 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20150318 LR - 20201001 IS - 1940-5901 (Print) IS - 1940-5901 (Electronic) IS - 1940-5901 (Linking) VI - 8 IP - 1 DP - 2015 TI - Functional characterization of OPN in human laryngeal squamous cell carcinoma and its xenograft model in nude mice. PG - 164-72 AB - BACKGROUND: Osteopontin (OPN) is involved in promotion of cancer cells by regulating various facets of tumor progression such as cell proliferation, angiogenesis and metastasis. To understand the role of OPN in laryngeal squamous cell carcinoma (LSCC), we thus explored the biological function of OPN in LSCC after silencing OPN expression by RNA interference (RNAi). METHOD: The OPN expression in tumor tissues of LSCC was determined immunohistochemically in both LSCC and adjacent normal tissues. Lentivirus vector with RNAi small hairpin gene sequence of OPN (named LV-shOPN) was transfected into Hep-2 cells and transplanted into BALB/c-nu mice. After siRNA transfection, the viability of Hep-2 cells was examined by MTS, OPN expression was detected by Western blotting, and tumor angiogenesis was assessed by microvessel densities (MVD). RESULTS: The difference of positive rate of OPN in 72 cases LSCC (54 cases, 75.0%) and adjacent normal tissues (15 cases, 20.8%) was statistically significant (P<0.001) and the OPN expression was also significantly correlated with tumor stage, grade and the presence of lymph node. Hep-2 cells infected with LV-shOPN significantly decreased OPN expression, in comparison to cells with LV-shNon transfection (as the control) (P<0.05). The constructed LV-shOPN effectively inhibited the viability of Hep-2 cell and growth of xenograft tumors in nude mice (all P<0.050). The expression of OPN and MVD was significantly decreased in xenograft tumors (all P<0.05). CONCLUSION: RNAi silencing of OPN expression can significantly inhibit tumor growth and angiogenesis of Hep-2 cells, and OPN may be considered as one of gene targeting therapy for LSCC. FAU - Chen, Jianqiu AU - Chen J AD - Department of Otolaryngology Head and Neck Surgery, General Hospital of Jinan Military Region Jinan 250031, Shandong Province, PR China. FAU - Zhou, Qi AU - Zhou Q AD - Department of Tumor Biological Treatment, The Third Affiliated Hospital, Soochow University Changzhou 213003, Jiangsu Province, China. FAU - Zhu, Chunsheng AU - Zhu C AD - Department of Otolaryngology Head and Neck Surgery, General Hospital of Jinan Military Region Jinan 250031, Shandong Province, PR China. FAU - Zhu, Minhui AU - Zhu M AD - Department of Otolaryngology Head and Neck Surgery, Changhai Hospital of The Second Military Medical University Shanghai 200433, PR China. FAU - Tian, Yongsheng AU - Tian Y AD - Department of Otolaryngology Head and Neck Surgery, Aerospace Center Hospital of Beijing university Beijing 100049, PR China. FAU - Li, Guojun AU - Li G AD - Department of Head and Neck Surgery, U.T. M.D. Anderson Cancer Center Houston, TX 77030, USA. FAU - Tao, Xiaofeng AU - Tao X AD - Department of Radiology, Shanghai Ninth People's Hospital Affiliated Shanghai Jiaotong University School of Medicine China. FAU - Zheng, Hongliang AU - Zheng H AD - Department of Otolaryngology Head and Neck Surgery, Changhai Hospital of The Second Military Medical University Shanghai 200433, PR China. LA - eng PT - Journal Article DEP - 20150115 PL - United States TA - Int J Clin Exp Med JT - International journal of clinical and experimental medicine JID - 101471010 PMC - PMC4358440 OTO - NOTNLM OT - Osteopontin OT - RNA interference OT - laryngeal neoplasms OT - laryngeal squamous cell carcinoma OT - nude mice EDAT- 2015/03/19 06:00 MHDA- 2015/03/19 06:01 PMCR- 2015/01/15 CRDT- 2015/03/19 06:00 PHST- 2014/11/12 00:00 [received] PHST- 2015/01/14 00:00 [accepted] PHST- 2015/03/19 06:00 [entrez] PHST- 2015/03/19 06:00 [pubmed] PHST- 2015/03/19 06:01 [medline] PHST- 2015/01/15 00:00 [pmc-release] PST - epublish SO - Int J Clin Exp Med. 2015 Jan 15;8(1):164-72. eCollection 2015.